Updated: May 18, 2026

Thomas P. O'Neil

Satsuma Pharmaceuticals, Inc.SEC CIK: 0001640645
Estimated Net Worth
$1.63 Million0.0%vs Last Year
Last Updated: May 18, 2026 11:23 PM EST

Transaction Summary

Total Transactions18
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions8

Transaction Volume

Total Volume-$351.35K
Net Volume$351.35K
Buy Volume$0.00
Sell Volume-$351.35K

Trade Analysis

AVG Trade Size-$20.22K
Largest Trade$0.00
Most Active MonthJun
Most Active Year2020

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Thomas P. O'Neil has an estimated net worth of $1.63 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, Arcadia Biosciences, Inc., and Satsuma Pharmaceuticals, Inc..



2020 was Thomas P. O'Neil's most active year for acquiring shares with 11 total transactions. Thomas P. O'Neil's most active month to acquire stocks was the month of May. 2020 was Thomas P. O'Neil's most active year for disposing of shares, totalling 16 transactions. Thomas P. O'Neil's most active month to dispose stocks was the month of May. 2017 saw Thomas P. O'Neil paying a total of $21,480.00 for 8,000 shares, this is the most they've acquired in one year. In 2017 Thomas P. O'Neil cashed out on 16,000 shares for a total of $160,000.00, their largest year based on trade value.

Holdings & Transactions

satsuma pharmaceuticals, inc.
Chief Financial Officer Officer
Updated: Jun 08, 2023
Form TypeSEC Filing
-1.00492.81K$0.91-$12.63KJun 06 - 08View
190.00K190.00KJun 03View
80.00K80.00KDec 03View
-0.01750.00$13.38-$13.22K65.59KScheduledSep 01View
-0.011.00K$14.78-$20.44K66.34KScheduledAug 05View
-0.011.00K$15.60-$22.09K67.34KScheduledJul 01View
-0.032.12K$18.13-$72.31K74.48KScheduledJun 23View
-0.011.00K$14.94-$20.76K68.34KScheduledJun 01View
-0.032.00K$14.78-$40.88K69.34KScheduledMay 20View
-0.011.00K$16.12-$23.12K71.34KScheduledMar 11View
60.00K60.00KMar 04View
View
PTGXprotagonist therapeutics, inc
Chief Financial Officer Officer
Updated: Aug 17, 2018VIEW QUOTE
Form TypeSEC Filing
3.7235.15K44.61KAug 15View
14.0040.00K42.86KFeb 28View
-0.088.00K$11.35-$138.52K94.66KScheduledDec 18View
45.00K45.00KOct 11View
View
RKDAarcadia biosciences, inc.
Chief Financial Officer Officer
Updated: May 14, 2015VIEW QUOTE
Form TypeSEC Filing
View